X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with TTK HEALTHCARE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs TTK HEALTHCARE - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH TTK HEALTHCARE STERLING BIOTECH/
TTK HEALTHCARE
 
P/E (TTM) x -1.6 50.7 - View Chart
P/BV x 0.1 9.3 0.7% View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 STERLING BIOTECH   TTK HEALTHCARE
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
TTK HEALTHCARE
Mar-14
STERLING BIOTECH/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs11663 1.6%   
Low Rs3399 0.9%   
Sales per share (Unadj.) Rs26.8535.6 5.0%  
Earnings per share (Unadj.) Rs-15.015.9 -93.8%  
Cash flow per share (Unadj.) Rs-5.520.0 -27.3%  
Dividends per share (Unadj.) Rs04.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs54.9137.6 39.9%  
Shares outstanding (eoy) m267.877.77 3,447.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.0 26.1%   
Avg P/E ratio x-0.533.3 -1.4%  
P/CF ratio (eoy) x-1.326.5 -4.8%  
Price / Book Value ratio x0.13.9 3.3%  
Dividend payout %025.1 0.0%   
Avg Mkt Cap Rs m1,8624,127 45.1%   
No. of employees `0001.41.7 79.3%   
Total wages/salary Rs m547607 90.1%   
Avg. sales/employee Rs Th5,303.32,436.7 217.6%   
Avg. wages/employee Rs Th403.8355.2 113.7%   
Avg. net profit/employee Rs Th-2,959.072.5 -4,079.1%   
INCOME DATA
Net Sales Rs m7,1814,162 172.5%  
Other income Rs m4361 69.6%   
Total revenues Rs m7,2234,223 171.0%   
Gross profit Rs m947197 480.4%  
Depreciation Rs m2,54332 8,022.7%   
Interest Rs m4,37730 14,639.1%   
Profit before tax Rs m-5,931197 -3,015.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,92473 -2,643.3%   
Profit after tax Rs m-4,007124 -3,233.7%  
Gross profit margin %13.24.7 278.4%  
Effective tax rate %32.437.0 87.7%   
Net profit margin %-55.83.0 -1,874.2%  
BALANCE SHEET DATA
Current assets Rs m14,3351,629 880.1%   
Current liabilities Rs m49,8091,058 4,708.8%   
Net working cap to sales %-494.013.7 -3,601.4%  
Current ratio x0.31.5 18.7%  
Inventory Days Days40330 1,354.7%  
Debtors Days Days17134 508.0%  
Net fixed assets Rs m55,432556 9,964.5%   
Share capital Rs m26878 344.8%   
"Free" reserves Rs m13,935878 1,586.6%   
Net worth Rs m14,7011,069 1,374.8%   
Long term debt Rs m9,478159 5,972.2%   
Total assets Rs m73,9882,399 3,083.6%  
Interest coverage x-0.47.6 -4.7%   
Debt to equity ratio x0.60.1 434.4%  
Sales to assets ratio x0.11.7 5.6%   
Return on assets %0.56.4 7.8%  
Return on equity %-27.311.6 -235.2%  
Return on capital %-6.418.5 -34.8%  
Exports to sales %25.90.8 3,276.3%   
Imports to sales %0.21.4 12.1%   
Exports (fob) Rs m1,86033 5,652.9%   
Imports (cif) Rs m1258 20.9%   
Fx inflow Rs m1,86033 5,652.9%   
Fx outflow Rs m2563 39.4%   
Net fx Rs m1,835-30 -6,057.8%   
CASH FLOW
From Operations Rs m1,719127 1,357.6%  
From Investments Rs m-3,148-146 2,156.3%  
From Financial Activity Rs m1,42622 6,511.4%  
Net Cashflow Rs m-33 -136.0%  

Share Holding

Indian Promoters % 33.9 65.4 51.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.7 -  
FIIs % 9.9 5.2 190.4%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 25.8 152.3%  
Shareholders   21,482 12,723 168.8%  
Pledged promoter(s) holding % 55.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   MERCK LTD  IPCA LABS  JUBILANT LIFE SCIENCES  VENUS REMEDIES  PIRAMAL ENTERPRISES  

Compare STERLING BIOTECH With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Day Flat; Oil and Gas Stocks Lead Losses(Closing)

After opening the day in red, share markets in India witnessed negative trading activity throughout the day and ended the day on a weak note.

Related Views on News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Feb 22, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 5-YR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS